Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Jun-2026 | 524.5 | 543.9 | 523.2 | 524.65 | 9,551 | 9,11,48,362.9 | 75,058 |
02-Jun-2026 | 520.95 | 533.4 | 517 | 531.25 | 6,383 | 4,63,65,696.55 | 41,773 |
03-Jun-2026 | 531.9 | 545 | 529 | 540.45 | 8,362 | 7,98,12,186.65 | 83,158 |
04-Jun-2026 | 540.5 | 572.7 | 538.2 | 555.5 | 14,774 | 18,20,78,602.3 | 1,44,342 |
05-Jun-2026 | 559.5 | 564.9 | 548.3 | 553.8 | 5,148 | 5,34,66,970.95 | 52,327 |
08-Jun-2026 | 553.05 | 557.5 | 542.85 | 545.35 | 6,399 | 4,72,34,813.85 | 40,614 |
09-Jun-2026 | 545.35 | 560.75 | 543.75 | 548.25 | 18,154 | 21,35,08,582.75 | 2,75,658 |
10-Jun-2026 | 546 | 595.9 | 545 | 592.1 | 41,855 | 81,12,22,036.55 | 4,94,748 |
11-Jun-2026 | 593.9 | 621 | 587.5 | 609.1 | 56,000 | 1,21,03,59,785.05 | 5,63,005 |
12-Jun-2026 | 615 | 634 | 615 | 622.9 | 29,647 | 52,23,94,140.8 | 3,18,990 |
15-Jun-2026 | 629.9 | 635 | 613.9 | 619.95 | 19,920 | 27,33,55,799.55 | 1,81,828 |
16-Jun-2026 | 622.9 | 622.9 | 590.6 | 596.85 | 19,480 | 18,79,49,195.5 | 1,58,031 |
17-Jun-2026 | 598 | 608.5 | 588 | 591.55 | 13,495 | 16,14,95,028.7 | 1,32,064 |
18-Jun-2026 | 591.6 | 605.1 | 591.55 | 601.7 | 12,136 | 10,77,67,695.85 | 87,765 |
19-Jun-2026 | 602.05 | 608.35 | 596.1 | 604.7 | 6,788 | 6,74,52,995.7 | 47,582 |
22-Jun-2026 | 615 | 623 | 599.15 | 617.25 | 11,870 | 11,38,91,270.45 | 97,776 |
23-Jun-2026 | 618.95 | 633.8 | 615.2 | 619.15 | 16,613 | 18,09,28,025.2 | 1,27,047 |
24-Jun-2026 | 624.9 | 639 | 611.6 | 613.6 | 10,357 | 12,64,23,860.9 | 96,749 |
25-Jun-2026 | 617 | 619.25 | 607.6 | 609.35 | 11,168 | 13,28,53,803.5 | 1,10,950 |
29-Jun-2026 | 609 | 630.9 | 608.95 | 624.65 | 14,152 | 14,32,33,743.85 | 1,19,671 |
30-Jun-2026 | 629 | 642.9 | 622 | 623.15 | 14,070 | 21,16,00,713.95 | 1,88,572 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
